Fetal growth is increased by maternal type 1 diabetes and HLA DR4-related gene interactions
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Aims/hypothesis Intrauterine growth in non-diabetic pregnancies is reported to be influenced by type 1 diabetes susceptibility genes. In particular, the high-risk HLA DR4_DQB1*0302 haplotype is associated with increased birthweight. The aim of this study was to determine whether HLA DR4 was associated with increased birthweight in a maternal diabetes environment and whether effects persisted during early childhood.Subjects and methods Birthweight and gestational age were obtained in singleton births from mothers with type 1 diabetes (n = 1161) or whose fathers or siblings have type 1 diabetes (n = 872). Weight and height at ages 2 and 5 years were obtained from paediatric records. Data were adjusted for (gestational) age and sex and expressed as percentiles of German reference data. HLA DR typing was obtained for all children and 1090 children also had insulin gene (INS) variable number of tandem repeats (VNTR) typing.Results Maternal type 1 diabetes was associated with increased birthweight, gestational age and birthweight percentiles (all p < 0.0001). In children of mothers with type 1 diabetes, birthweight percentile was further related to maternal HbA(1c) during pregnancy (r = 0.26; p < 0.0001) and was independently increased if children had HLA DR4 alleles (76th vs 64th percentile; p < 0.0001). HLA DR4 was not associated with birthweight in children of non-diabetic mothers. Birthweight was not associated with INS VNTR genotypes. High birthweight, but not HLA DR4 was associated with increased weight and BMI at ages 2 and 5 years (p < 0.0001).Conclusions/interpretation Our findings are consistent with the hypothesis that a diabetic intrauterine environment interacts with gene(s) marked by the type 1 diabetes susceptibility HLA DR4 alleles to increase fetal growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the second and third trimesters, A1C <6% (<42 mmol/mol) has the lowest risk of large-for-gestational-age infants (40,43,44), preterm delivery (45), and preeclampsia (1,46).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [43]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Buchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
Overweight in Children and Adolescents: Pathophysiology, Consequences, Prevention, and Treatment
Daniels, S. R., Arnett, D. K., Eckel, R. H., Gidding, S. S., Hayman, L. L., Kumanyika, S., Robinson, T. N., Scott, B. J., St. Jeor, S., & Williams, C. L. (2005) · Circulation · doi:10.1161/01.cir.0000161369.71722.10 · Cited by 1,550 · cited 1×
“In Western countries, the proportion of overweight children has reached unprecedented levels and rising weight trends are likely to contribute to increased incidences of type 1 diabetes, type 2 diabetes and cardiovascular disease [1, 2].”
BackgroundChildhood predictors of adult obesity: a systematic review.
Parsons, T. J., Power, C., Logan, S., & Summerbell, C. (1999) · PubMed · Cited by 1,289
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s88 · Cited by 916
Bennett, S. T., Lucassen, A. M., Gough, S. C. L., Powell, E. E., Undlien, D. E., Pritchard, L. E., Merriman, M. E., Kawaguchi, Y., Dronsfield, M. J., Pociot, F., et al. (1995) · Nature Genetics · doi:10.1038/ng0395-284 · Cited by 746 · cited 14×
“Birthweight was not associated with INS VNTR genotypes.”
MethodInfluentialMaternal Gestational Diabetes, Birth Weight, and Adolescent Obesity
Gillman, M. W., Rifas-Shiman, S., Berkey, C. S., Field, A. E., & Colditz, G. A. (2003) · Pediatrics · doi:10.1542/peds.111.3.e221 · Cited by 708 · cited 1×
“been reported to affect weight trends in children and adolescents, suggesting that some programming of weight status occurs in utero [5–8].”
BackgroundZiegler, A. G., Hummel, M., Schenker, M., & Bonifacio, E. (1999) · Diabetes · doi:10.2337/diabetes.48.3.460 · Cited by 645
Self-citationThe accelerator hypothesis: weight gain as the missing link between type I and type II diabetes
Wilkin, T. J. (2001) · Diabetologia · doi:10.1007/s001250100548 · Cited by 623
Long-term prospective evaluation of offspring of diabetic mothers
Silverman, B. L., Rizzo, T., Green, O. C., Cho, N. H., Winter, R. J., Ogata, E. S., Richards, G. E., & Metzger, B. E. (1991) · Diabetes · doi:10.2337/diab.40.2.s121 · Cited by 452 · cited 1×
“Maternal diabetes increases birthweight [10, 11].”
Warram, J. H., Krolewski, A. S., Gottlieb, M. S., & Kahn, C. R. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407193110304 · Cited by 392
Research works printed but not linked: 2
- Kimura A, Sasazuki T (1992) 11th International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa A, Sasazuki T (eds) HLA. Vol. 1, Oxford University Press, Oxford pp 397–419
- Fradin D, Boileau P, Lepercq J, Bougneres P (2006) ‘Non-Mendelian’ genetics of fetal growth. J Endocrinol Invest 29(Suppl 1):11–15
Cited by
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
The Environmental Determinants of Diabetes in the Young (TEDDY) Study
TEDDY Study Group (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.062 · Cited by 306
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 284
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s014 · Cited by 268
14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s014 · Cited by 265
“In the second and third trimesters, A1C,6% (42 mmol/mol) has the lowest risk of large-for-gestational-age infants (25,28,29), preterm delivery (30), and preeclampsia (1,31).”
Background15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s015 · Cited by 232
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s015 · Cited by 169
Larsson, H. E., Hansson, G., Carlsson, A., Cedervall, E., Jönsson, B., Jönsson, B., Larsson, K., Lynch, K. F., Neiderud, J., Lernmark, Å., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1074-0 · Cited by 61
“Previous studies have reported a relationship between high birthweight and both low-risk [39] and high-risk [14, 15] HLA genotypes.”
BackgroundResultBonifacio, E. E., Pflüger, M., Marienfeld, S., Winkler, C., Hummel, M., & Ziegler, A. (2008) · Diabetologia · doi:10.1007/s00125-008-1022-z · Cited by 48
Self-citationThe countdown to type 1 diabetes: when, how and why does the clock start?
Ziegler, A.-G. (2023) · Diabetologia · doi:10.1007/s00125-023-05927-2 · Cited by 30
Self-citationWinkler, C., Marienfeld, S., Zwilling, M., Bonifacio, E. E., & Ziegler, A. (2009) · Diabetologia · doi:10.1007/s00125-009-1461-1 · Cited by 31
Self-citationPeet, A., Kool, P., Ilonen, J., Knip, M., Tillmann, V., & for the DIABIMMUNE Study Group (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2303 · Cited by 31
“In our study, such a standardized curve was available only for the Finnish cohort [25].”
Pre-Gestational Diabetes and Pregnancy Outcomes
Ali, D. S., Davern, R., Rutter, E., Coveney, C., Devine, H., Walsh, J., Higgins, M., & Hatunic, M. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00932-9 · Cited by 28
Maternal Influences on Fetal Neurodevelopment: Clinical and Research Aspects
Zimmerman, A. W., & Connors, S. L. (2010) · Springer eBooks · doi:10.1007/978-1-60327-921-5 · Cited by 18
for the TEDDY Study Group, Sterner, Y., Törn, C., Lee, H.-S., Larsson, H. E., Winkler, C., McLeod, W., Lynch, K. F., Simell, O., Ziegler, A., et al. (2011) · Journal of Perinatology · doi:10.1038/jp.2011.26 · Cited by 12
Self-citationWinkler, C., Illig, T., Koczwara, K., Bonifacio, E. E., & Ziegler, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0970 · Cited by 12
Self-citationJärvinen, T. M., Harjutsalo, V., Kinnunen, L., Miettinen, M. E., Tuomilehto‐Wolf, E., & Tuomilehto, J. O. (2008) · Genes and Immunity · doi:10.1038/gene.2008.3 · Cited by 9
Shin, S., Yoon, J. H., Lee, H. R., Hwang, S. M., & Roh, E. Y. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq011 · Cited by 5
“The association of HLA genotype with birthweight has mainly been evaluated in diabetes mellitus (DM) patients or families, and only a few reports limited to Caucasians revealed that certain HLA genotypes are associated with the birthweight of healthy neonates (Stene et al., 2001; Larsson et al., 2005; Hummel et al., 2…”
BackgroundInfluentialA Pragmatic Approach to the Treatment of Women With Type 2 Diabetes in Pregnancy
Bender, W. R., & Durnwald, C. P. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000592 · Cited by 3
Johnson, W. G., Buyske, S. G., Stenroos, E. S., & Lambert, G. H. (2010) · Springer eBooks · doi:10.1007/978-1-60327-921-5_9 · Cited by 2
“The fetal haplotype HLA-DR4_DQB1*0302, the haplotype conferring the highest risk for Type I diabetes mellitus, is reportedly associated with intrauterine growth alterations, such as increased relative birth weight, in normal pregnancies [101] as well as in pregnancies of mothers with Type I diabetes [102].”
BackgroundDURATION OF BREASTFEEDING AND PRESENCE OF CHILDHOOD OVERWEIGHT AT 3 YEARS OF AGE
Abdella, R. (2012) · Tampere University Institutional Repository (Tampere University)
The Gene-Environment Interaction in Asperger's Disorder
Johnson, M. E., Sanders, C., & Rausch, J. L. (2008) · Medical psychiatry · doi:10.3109/9780849383649.011 · Cited by 1
Autism, Teratogenic Alleles, HLA-DR4, and Immune Function
Johnson, W. G., Buyske, S. G., Stenroos, E. S., & Lambert, G. H. (2009) · CRC Press eBooks · doi:10.1201/9781420068870-c17
Perinatal risk factors for type 1 diabetes in children and adolescents
Lindell, N. (2021) · Linköping University medical dissertations · doi:10.3384/diss.diva-180918 · Cited by 1
(2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32830c6b8e
Current literature in diabetes
(2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.787
Metformin use during pregnancy: Current evidence and clinical considerations
Kazakova, T., Zamtikova, M., Zaykov, H., Ivanova, M., & Тодорова, А. (2026) · Scripta Scientifica Medica · doi:10.14748/r6s8n597
“Nevertheless, the FDA is revising its labelling based on emerging evidence from clinical trials on the use of metformin during pregnancy [14].”
Metadata
- Authors
- Hummel, M., Marienfeld, S., Huppmann, M., Knopff, A., Voigt, M., Bonifacio, E., & Ziegler, A.-G.
- Affiliations
- München Klinik Schwabing (DE)
- Universitätsmedizin Greifswald (DE)
- IRCCS Ospedale San Raffaele (IT)
- Corresponding author
- Ziegler, A.-G.
- Venue
- Diabetologia
- Published
- 2007-02-20
- Volume
- 50
- Issue
- 4
- Pages
- 850-858
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2036138762
- Cited by
- 29
- References
- 43
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 1 · 2012: 2
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- Deutsche Forschungsgemeinschaft (/14-1)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 1 diabetes, maternal diabetes, fetal growth, birth weight, HLA-DR4, HLA-DQB1*0302, gene-environment interaction, intrauterine environment, child growth, childhood BMI
- MeSH terms
- Birth Weight, Diabetes Mellitus, Type 1, Female, Gestational Age, Haplotypes, Humans, Insulin, Male, Models, Genetic, Pregnancy, Cohort Studies, HLA-DR4 Antigen, Multivariate Analysis, Diabetes, Gestational, Fetal Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.